Clinical trial
Prediction of Adverse Events in Children and Adolescents With Cancer at High Risk of Infection (PREDSEQ)
NCT03226158 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of Adverse Events in Children and Adolescents With Cancer at High Risk of Infection (PREDSEQ)
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 9, 2017
- Completion date
- July 1, 2027
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bloodstream infection